Pages that link to "Q24624885"
Jump to navigation
Jump to search
The following pages link to Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation (Q24624885):
Displaying 50 items.
- Ivacaftor for patients with cystic fibrosis (Q22305938) (← links)
- Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis (Q24187139) (← links)
- Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences (Q26747210) (← links)
- Computed tomography dose optimisation in cystic fibrosis: A review (Q26751283) (← links)
- Advancing clinical development pathways for new CFTR modulators in cystic fibrosis (Q26768266) (← links)
- Targeted therapies to improve CFTR function in cystic fibrosis (Q26781441) (← links)
- Cystic fibrosis transmembrane conductance regulator dysfunction and its treatment (Q26851242) (← links)
- Cystic fibrosis chronic rhinosinusitis: a comprehensive review (Q27003313) (← links)
- Cystic fibrosis therapeutics: the road ahead (Q27022401) (← links)
- Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice (Q27303954) (← links)
- A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in cystic fibrosis (Q27331812) (← links)
- Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences (Q27676826) (← links)
- Understanding protein kinase CK2 mis-regulation upon F508del CFTR expression (Q27694649) (← links)
- Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives (Q28073063) (← links)
- CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis (Q28073996) (← links)
- Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms (Q28077411) (← links)
- Origins of cystic fibrosis lung disease (Q28080451) (← links)
- Precision Genomic Medicine in Cystic Fibrosis (Q28080906) (← links)
- Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis (Q28276595) (← links)
- Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability (Q28535395) (← links)
- Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation (Q28544842) (← links)
- Potentiation of ΔF508- and G551D-CFTR-Mediated Cl- Current by Novel Hydroxypyrazolines (Q28550065) (← links)
- Cystic fibrosis related liver disease--another black box in hepatology (Q28655881) (← links)
- A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease (Q28727685) (← links)
- Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications (Q28830793) (← links)
- Barriers to inhaled gene therapy of obstructive lung diseases: A review (Q29248141) (← links)
- The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability (Q30394029) (← links)
- Development of CFTR Structure (Q30421217) (← links)
- Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology (Q30421643) (← links)
- Harnessing public domain data to discover and validate therapeutic targets (Q30491667) (← links)
- Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility. (Q30540580) (← links)
- Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data (Q30784080) (← links)
- The ΔF508-CFTR mutation inhibits wild-type CFTR processing and function when co-expressed in human airway epithelia and in mouse nasal mucosa (Q31099925) (← links)
- A little CFTR goes a long way: CFTR-dependent sweat secretion from G551D and R117H-5T cystic fibrosis subjects taking ivacaftor (Q31151483) (← links)
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype (Q33633486) (← links)
- Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation (Q33654992) (← links)
- Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy. (Q33742766) (← links)
- Toll-Like Receptor 4 Engagement Mediates Prolyl Endopeptidase Release from Airway Epithelia via Exosomes (Q33756865) (← links)
- In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies (Q33769791) (← links)
- Factors influencing quality of life and disease severity in Hungarian children and young adults with cystic fibrosis (Q33798903) (← links)
- CFTR Modulators for the Treatment of Cystic Fibrosis (Q33920366) (← links)
- Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling. (Q33960117) (← links)
- The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients (Q34016488) (← links)
- Defective fluid secretion from submucosal glands of nasal turbinates from CFTR-/- and CFTR (ΔF508/ΔF508) pigs (Q34025925) (← links)
- Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs (Q34031395) (← links)
- Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner (Q34033437) (← links)
- Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds (Q34044741) (← links)
- Novel insights related to CF neutrophils (Q34047910) (← links)
- A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy (Q34047949) (← links)
- Molecular pathogenesis of spondylocheirodysplastic Ehlers-Danlos syndrome caused by mutant ZIP13 proteins (Q34131175) (← links)